REGULATE

 

The aim of this study is to determine the efficacy of REG1 compared to bivalirudin in preventing periprocedural ischemic complications and major bleeding in patients undergoing PCI as a treatment for CAD.

This Study Is Closed To Enrollment.

 

©2018 Heart Consultants P.C. All Rights Reserved